ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards

July 13, 1990

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

October 24, 1996

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991